Multivariate analysis of physicochemical characteristics of lipid based nanoemulsifying cilostazol-Quality by design

Colloids and Surfaces B: Biointerfaces

Volumn 115, Issue , 2014, Pages 29-36

  Pund, Swati ^a   Shete, Yogesh ^a   Jagadale, Sujata ^a  

^a Sinhgad Institute of Pharmacy   (India)

Author keywords

Adsorption; Cilostazol; Multivariate analysis; Nanoemulsion; Quality by design; Solubility

Indexed keywords

ADSORPTION; BIOCHEMISTRY; DESIGN; DISSOLUTION; MULTIVARIANT ANALYSIS; OPTIMIZATION; POLYNOMIALS; SOLUBILITY; ZETA POTENTIAL;

CILOSTAZOL; DISSOLUTION EFFICIENCIES; EQUILIBRIUM SOLUBILITIES; MULTI VARIATE ANALYSIS; NANOEMULSION; PHYSICOCHEMICAL CHARACTERISTICS; PHYSICOCHEMICAL PROPERTY; QUALITY BY DESIGNS;

QUALITY CONTROL;

CILOSTAZOL; DIETHYLENE GLYCOL MONOETHYL ETHER; LIPID; OCTANOIN; POLYSORBATE 80; WATER; ALUMINUM DERIVATIVE; ATTAPULGITE; EMULSION; MAGNESIUM DERIVATIVE; NANOPARTICLE; SILICATE; TETRAZOLE DERIVATIVE;

ADSORPTION; ARTICLE; BAYES THEOREM; CHEMICAL COMPOSITION; CHEMICAL INTERACTION; CONTROLLED STUDY; DILUTION; DRUG BIOAVAILABILITY; DRUG DESIGN; DRUG FORMULATION; DRUG QUALITY; DRUG SOLUBILITY; EXPERIMENTAL DESIGN; FACTORIAL DESIGN; GLOBULE SIZE; MATHEMATICAL MODEL; MULTIVARIATE ANALYSIS; NANOEMULSION; PHYSICAL CHEMISTRY; PHYSICAL PARAMETERS; PRIORITY JOURNAL; PROCESS OPTIMIZATION; SPAN; ZETA POTENTIAL; CHEMISTRY; DRUG EFFECTS; EMULSION; MOLECULAR WEIGHT; PARTICLE SIZE; REPRODUCIBILITY; SOLUBILITY; STATIC ELECTRICITY; THEORETICAL MODEL; ULTRASTRUCTURE;

ADSORPTION; ALUMINUM COMPOUNDS; DRUG DESIGN; EMULSIONS; LIPIDS; MAGNESIUM COMPOUNDS; MODELS, THEORETICAL; MOLECULAR WEIGHT; MULTIVARIATE ANALYSIS; NANOPARTICLES; PARTICLE SIZE; PHYSICOCHEMICAL PHENOMENA; REPRODUCIBILITY OF RESULTS; SILICATES; SOLUBILITY; STATIC ELECTRICITY; TETRAZOLES;

EID: 84889606511     PISSN: 09277765     EISSN: 18734367     Source Type: Journal    
DOI: 10.1016/j.colsurfb.2013.11.019     Document Type: Article

References (29)

1. Jinno J., Kamada N., Miyake M., Yamada K., Mukai T., Odomi M., Toguchi H., Liversidge G.G., Higaki K., Kimura T. Effect of particle size reduction on dissolution and oral absorption of a poorly water-soluble drug, cilostazol, in beagle dogs. J. Control. Release. 2006, 111:56-64.
2. Patel S.G., Rajput S.J. Enhancement of oral bioavailability of cilostazol by forming its inclusion complexes. AAPS PharmSciTech. 2009, 10(2):660-669.
3. Bramer S.L., Forbes W.P. Relative bioavailability and effects of a high fat meal on single dose cilostazol pharmacokinetics. Clin. Pharmacokinet. 1999, 37(Suppl. 2):13-23.
4. Dindyal S., Kyriakides C. A Review of Cilostazol, a Phosphodiesterase Inhibitor, and its role in preventing both coronary and peripheral arterial restenosis following endovascular therapy. Recent Pat. Cardiovasc. Drug Discov. 2009, 4:6-14.
5. Villar A.M.S., Naveros B.C., Campmany A.C.C., Trenchs M.A., Aróztegui M., Rocabert B., Bellowa L.H. Design and optimization of self-nanoemulsifying drug delivery systems (SNEDDS) for enhanced dissolution of gemfibrozil. Int. J. Pharm. 2012, 431:161-175.
6. Porter C.J.H., Pouton C.W., Cuine J.F., Charman W.N. Enhancing intestinal drug solubilisation using lipid-based delivery systems. Adv. Drug Deliv. Rev. 2008, 60:673-691.
7. Singh B., Bhatowa R., Tripathi C.B., Kapil R. Developing micro-/nanoparticulate drug delivery systems using design of experiment. Int. J. Pharm. Investig. 2011, 1(2):75-87.
8. Singh B., Chakkal S., Ahuja N. Formulation and optimization of controlled release mucoadhesive tablets of Atenolol using response surface methodology. AAPS PharmSciTech. 2006, 7(1):E1-E10.
9. Huang J., Goolcharran C., Ghosh K. A Quality by Design approach to investigate tablet dissolution shift upon accelerated stability by multivariate methods. Eur. J. Pharm. Biopharm. 2011, 78(1):141-150.
10. Singh B., Kapil R., Nandi M., Ahuja N. Developing oral drug delivery systems using formulation by design: vital precepts, retrospect and prospects. Expert Opin. Drug Deliv. 2011, 8(10):1341-1360.
11. Charoo N.A., Shamsher A.A.A., Zidan A.S., Rahman Z. Quality by design approach for formulation development: a case study of dispersible tablets. Int. J. Pharm. 2012, 423(2):167-178.
12. Huang J., Kaul G., Cai C., Chatlapalli R., Hernandez-Abad P., Ghosh K., Nagi A. Quality by design case study: an integrated multivariate approach to drug product and process development. Int. J. Pharm. 2009, 382(1-2):23-32.
13. Wu H., White M., Khan M.A. Quality-by-Design (QbD): an integrated process analytical technology (PAT) approach for a dynamic pharmaceutical co-precipitation process characterization and process design space development. Int. J. Pharm. 2011, 405:63-78.
14. Pund S., Joshi A., Vasu K., Nivsarkar M., Shishoo C. Multivariate optimization of formulation and process variables influencing physico-mechanical characteristics of site-specific release isoniazid pellets. Int. J. Pharm. 2010, 388:64-72.
15. Patil S., Pund S., Joshi A., Shishoo C., Shahiwala A. Chronomodulated press-coated pulsatile therapeutic system for aceclofenac: optimization of factors influencing drug release and lag time. ChronoPhysiol. Ther. 2011, 1:1-10.
16. Matos M., Gutiérrez G., Coca J., Pazos C. Preparation of water-in-oil-in-water (W1/O/W2) double emulsions containing trans - resveratrol. Colloids Surf. A Physicochem. Eng. Aspects 2013, 10.1016/j.colsurfa.2013.05.065.
17. Pund S., Borade G., Rasve G. Improvement of anti-inflammatory and anti-angiogenic activity of berberine by novel rapid dissolving nanoemulsifying technique. Phytomedicine. 2013, 10.1016/j.phymed.2013.09.013.
18. Costa P., Sousa Lobo J.M. Modelling and comparison of dissolution profiles. Eur. J. Pharm. Sci. 2001, 13(2):123-133.
19. Hauss D.J., Fogal S.E., Ficorilli J.V., Price C.A., Roy T., Jayaraj A.A., Keirns J.J. Lipid-based delivery systems for improving the bioavailability and lymphatic transport of a poorly water-soluble LTB4 inhibitor. J. Pharm. Sci. 1998, 87(2):164-169.
20. Craig D.Q.M., Barker S.A., Banning D., Booth S.W. An investigation into the mechanisms of self-emulsification using particle size analysis and low frequency dielectric spectroscopy. Int. J. Pharm. 1995, 114:103-110.
21. Miao X., Sun C., Jiang T., Zheng L., Wang T., Wang S. Investigation of nanosized crystalline form to improve the oral bioavailability of poorly water soluble cilostazol. J. Pharm. Pharm. Sci. 2011, 14:196-214.
22. Liu Y., Zhang P., Feng N., Zhang X., Wu S., Zhao J. Optimization and in situ intestinal absorption of self-microemulsifying drug delivery system of oridonin. Int. J. Pharm. 2009, 365:136-142.
23. Biradar S.V., Dhumal R.S., Paradkar A.R. Rheological investigation of self-emulsification process: effect of co-surfactant. J. Pharm. Pharm. Sci. 2009, 12(2):164-174.
24. Leung R., Shah D.O. Solubilization and phase equilibria of water-in-oil microemulsion. I. Effect of spontaneous curvature and elasticity of interfacial films. J. Colloid Interface Sci. 1987, 120(2):320-329.
25. Parmar N., Singla N., Amin S., Kohli K. Study of cosurfactant effect on nanoemulsifying area and development of lercanidipine loaded (SNEDDS) self nanoemulsifying drug delivery system. Colloids Surf. B Biointerfaces 2011, 86:327-338.
26. Gershanik T., Benzeno S., Benita S. Interaction of a Self-emulsifying lipid drug delivery system with the everated rat intestinal mucosa as a function of droplet size and surface charge. Pharm. Res. 1998, 15:863-869.
27. Zhao Y., Wang C., Chow A.H.L., Ren K., Gong T., Zhang Z., Zheng Y. Self nanoemulsifying drug delivery system (SNEDDS) for oral delivery of Zedoary essential oil: formulation and bioavailability studies. Int. J. Pharm. 2010, 383:170-177.
28. Kim M.-S., Kim J.-S., Hwang S.-J. Enhancement of wettability and dissolution properties of cilostazol using the supercritical antisolvent process: effect of various additives. Chem. Pharm. Bull. 2010, 58(2):230-233.
29. Sander C., Holm P. Porous magnesium aluminometasilicate tablets as carrier of a cyclosporine self-emulsifying formulation. AAPS PharmSciTech. 2009, 10:1388-1395.